Treatment of Hypertension With Adalat® in Combination With Other Drugs
AdADOSE - Antihypertensive Treatment With Adalat® in Different Doses and Combination Therapy
3 other identifiers
observational
4,497
11 countries
11
Brief Summary
To investigate the therapeutic effectiveness of long acting nifedipine containing combination therapy in the treatment of hypertensive patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2010
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
May 5, 2010
CompletedFirst Posted
Study publicly available on registry
May 6, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2011
CompletedJune 27, 2012
June 1, 2012
May 5, 2010
June 26, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of treatment success (lowering of blood pressure in mmHg) in adult hypertensive patients
After three months
Study Arms (1)
Group 1
Interventions
Previously untreated hypertensive adult patients starting with combination therapy containing nifedipine or insufficiently controlled hypertensive patients receiving nifedipine as an add-on to existing non-CCB containing antihypertensive therapy. The decision of including the patient as well as decision on dosage and duration is taken by the investigator.
Eligibility Criteria
Previously untreated hypertensive adult patients starting with combination therapy containing nifedipine or insufficiently controlled hypertensive patients receiving nifedipine as an add-on to existing non-CCB containing antihypertensive therapy
You may qualify if:
- Previously untreated hypertensive patients starting with combination therapy containing nifedipine or
- Insufficiently controlled hypertensive pts. receiving nifedipine as an add-on to existing non-CCB (calcium-channel-blocker) containing antihypertensive therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bayerlead
Study Sites (11)
Unknown Facility
Many Locations, Bahrain
Unknown Facility
Many Locations, Egypt
Unknown Facility
Many Locations, Jordan
Unknown Facility
Many Locations, Lebanon
Unknown Facility
Many Locations, Morocco
Unknown Facility
Many Locations, Oman
Unknown Facility
Many Locations, Pakistan
Unknown Facility
Many Locations, Qatar
Unknown Facility
Many Locations, Russia
Unknown Facility
Many Locations, Saudi Arabia
Unknown Facility
Many Locations, United Arab Emirates
Related Publications (1)
Motaweih AK, Usova E, Hussain W, Dello Z, Schmidt B, Petri T. Effectiveness of combination therapy with nifedipine GITS: a prospective, 12-week observational study (AdADOSE). BMC Cardiovasc Disord. 2015 May 9;15:35. doi: 10.1186/s12872-015-0037-x.
PMID: 25956918DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Bayer Study Director
Bayer
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
May 5, 2010
First Posted
May 6, 2010
Study Start
January 1, 2010
Study Completion
September 1, 2011
Last Updated
June 27, 2012
Record last verified: 2012-06